The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Sign in to access this content
Sign InWaters Corp reported robust financial results for the first quarter, exceeding both revenue and earnings per share (EPS) guidance. Following this strong performance, the company raised its 2026 organic constant-currency revenue growth outlook, signaling management's confidence in its long-term trajectory. A key driver of this success was the faster-than-planned integration of newly acquired assets from BD, which has already begun yielding strategic benefits. Despite facing headwinds in the Chinese market and the respiratory testing segment, strong operational execution helped bolster the bottom line. Analysts suggest that the earnings beat, combined with the upward revision of long-term guidance, strengthens the company's investment profile within the scientific instruments sector. Waters Corp remains focused on capturing synergies from its recent M&A activities to drive sustainable growth.